CIK 0001501796
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320271970
- Phone
- +1 617-500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 4 Open-market sale Kilroy Conor sold 11,738 shares at $7.02 ($82,401)
- 4 Grant or award Kilroy Conor acquired 62,339 shares (grant or award)
- 4 Grant or award Gibney Anthony S acquired 71,245 shares (grant or award)
- 4 Grant or award de los Pinos Elisabet acquired 166,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 62,339 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 89,056 shares (grant or award)
- 4 Grant or award Senior Vice President, Finance acquired 44,528 shares (grant or award)
- 4 Open-market sale Kilroy Conor sold 12,079 shares at $5.05 ($60,999)
- 4 Open-market sale Chief Technology Officer sold 15,890 shares at $5.05 ($80,245)
- 4 Open-market sale Chief Medical Officer sold 20,401 shares at $5.06 ($103,229)
- 4 Open-market sale Senior Vice President, Finance sold 8,549 shares at $5.06 ($43,258)
- 4 Open-market sale de los Pinos Elisabet sold 47,648 shares at $5.06 ($241,099)
- 4 Open-market sale Senior Vice President, Finance sold 1,581 shares at $4.86 ($7,684)
- 4 Open-market sale de los Pinos Elisabet sold 16,928 shares at $4.86 ($82,270)
- 4 Open-market sale Chief Medical Officer sold 17,109 shares at $5.42 ($92,731)
- 4 Open-market sale Senior Vice President, Finance sold 896 shares at $6.35 ($5,690)
- 4 Open-market sale de los Pinos Elisabet sold 9,049 shares at $6.35 ($57,461)
- 4 Open-market sale Chief Technology Officer sold 12,169 shares at $6.35 ($77,273)
- 4 Open-market sale Senior Vice President, Finance sold 7,722 shares at $6.70 ($51,737)
- 4 Grant or award Director acquired 13,000 shares (grant or award)
Page 2 of 7 · 137 filings